Capital Research Global Investors Conmed Corp Transaction History
Capital Research Global Investors
- $479 Billion
- Q2 2025
A detailed history of Capital Research Global Investors transactions in Conmed Corp stock. As of the latest transaction made, Capital Research Global Investors holds 1,676,164 shares of CNMD stock, worth $90.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,676,164
Previous 1,673,404
0.16%
Holding current value
$90.5 Million
Previous $101 Million
13.62%
% of portfolio
0.02%
Previous 0.02%
Shares
31 transactions
Others Institutions Holding CNMD
# of Institutions
303Shares Held
35.6MCall Options Held
75KPut Options Held
32.1K-
Black Rock Inc. New York, NY4.99MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.55MShares$192 Million0.0% of portfolio
-
Earnest Partners LLC Atlanta, GA2.83MShares$153 Million0.7% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.74MShares$94 Million0.34% of portfolio
-
Bank Of America Corp Charlotte, NC1.51MShares$81.5 Million0.01% of portfolio
About CONMED Corp
- Ticker CNMD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 30,482,400
- Market Cap $1.65B
- Description
- CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...